Serum MMP-9 concentrations ≥140 ng/ml were shown to predict hemorrhagic transformation in rt-PA treated ischemic stroke patients (sensitivity 92%, specificity 74%) (46). This evidence concerns the gene MMP9 and ischemic stroke.